Australian Medical Device Manufacturing HVAC Duct Guide — Cochlear, ResMed, Surgical Implant, Orthopaedic, Dental, IVD Diagnostic, CPAP & Ventilator

The Australian medical device manufacturing landscape — and why it drives HVAC duct spec

Australia is, by global standards, a medical device manufacturing country well above its population weight. Two ASX-listed primes — Cochlear Limited (ASX:COH) and ResMed (ASX:RMD) — sit as global category leaders in their respective therapeutic areas. Cochlear is the largest medical device company in Australia by market capitalisation, the global market leader in hearing implants, and the dominant exporter of bionic ear technology under the Nucleus, Baha, Osia and Acoustic brand families. ResMed is the global market leader in CPAP, ventilator and sleep apnoea therapy by revenue, with its Bella Vista Sydney headquarters anchoring Norwest, Mascot and Macquarie Park research and manufacturing footprints. Behind these two sits Nanosonics (ASX:NAN) — the global market leader in high-level disinfection of transoesophageal (TEE) and transvaginal (TVE) ultrasound probes through its trophon platform, manufactured at Lane Cove West with headquarters at Macquarie Park. Compumedics (ASX:CMP) at Abbotsford Victoria supplies neurodiagnostic, EEG, ECG and sleep monitoring equipment to a global hospital base. Polynovo (ASX:PNV) at Port Melbourne manufactures NovoSorb, the biodegradable polyurethane scaffold used in burns and reconstructive surgery. Telix Pharmaceuticals (ASX:TLX) crosses into the radiopharmaceutical category with Illuccix (Gallium-68 PSMA-11 PET imaging agent) — strictly speaking a drug rather than a device, but the manufacturing environment shares the same cleanroom HVAC framework.

Beneath the locally listed primes sits a deep ecosystem of Australian subsidiaries and contract manufacturers. Surgical and orthopaedic implant manufacturing is dominated by the local arms of Stryker Australia, Zimmer Biomet Australia, Johnson & Johnson DePuy Synthes, Smith+Nephew Australia, Medtronic Australia, Boston Scientific Australia, Abbott Australia, Edwards Lifesciences, B. Braun Australia, DJO Global, Implantcast and Australian Implant Pty Ltd. Dental implant volume runs through Straumann Australia, Nobel Biocare Australia, Megagen Australia, Osstem, Anatomic Implants (Australian-owned), AustraDent, Adin Australia, Camlog Australia, Ankylos, Bredent Australia, ICX, the Astra Tech line (now Dentsply-Sirona) Australia, and Implant Direct Australia. In-vitro diagnostic (IVD) manufacturing concentrates around Abbott Diagnostics Australia, Roche Diagnostics Australia at Dee Why NSW, Beckman Coulter Australia, Siemens Healthineers Australia, BD Becton Dickinson Australia, Bio-Rad Australia, Sysmex Australia, Hologic Australia (specialising in women's health), Sebia Australia (electrophoresis platforms) and Lonza Australia (Limulus Amebocyte Lysate, LAL, for endotoxin testing). The Australian-owned IVD specialists include Sienna Diagnostics, Lumos Diagnostics, Ellume Medical (the Brisbane rapid COVID home test manufacturer), Telstra Health and MedAdvisor. Respiratory and CPAP-adjacent manufacturers beyond ResMed include Air Liquide Healthcare, Philips Australia, Drager Australia and Vyaire Medical (formerly CareFusion). Hospital sterilisation and CSSD equipment is supplied by 3M Australia, STERIS, Belimed, Getinge and Sterling Sterilisation. Cardiovascular and catheter device assembly runs through Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Vascular, Cordis (J&J), AbbVie, Cook Medical, St Jude Medical (Abbott), Biotronik and Atrium. Wound dressing and chronic care is delivered by Smith+Nephew, ConvaTec Australia, 3M, Coloplast, Hartmann, Molnlycke Health Care, Ansell (ASX:ANN) and Smith Therapeutics. Diabetes care includes Roche, Abbott (Libre CGM platform), Medtronic Diabetes, Insulet, Dexcom, Animas and Tandem (insulin pumps and continuous glucose monitors). And the specialist contract manufacturer (CMO) tier includes Planet Innovation, Mac Medical, Adept, MedTech and DBL Technology.

Each of these organisations operates under the same overlapping regulatory and standards stack — TGA Therapeutic Goods Administration Class I/IIa/IIb/III for the medical device classification, FDA 510(k) or PMA for US-marketed product, CE Marking under MDR 2017/745 (or IVDR 2017/746 for in-vitro diagnostic) for European market access, ISO 13485:2016 as the quality management system, TGO 92 (Therapeutic Goods Order 92) as the Australian manufacturing standard, ISO 14644 as the cleanroom classification, AS/NZS 4187 where reusable devices intersect with sterile reprocessing, AS/NZS 60079 where the manufacturing process generates flammable atmosphere, and an industry-driven sterilisation standard family (ISO 11135 for EtO, ISO 17665 for steam autoclave, ISO 11137 for radiation, ISO 14160 for liquid chemical, ISO 14937 as the generic sterilisation framework). The HVAC duct designer's job is to translate this stack into the specific materials, dimensions, finishes, welds, dampers and documentation that the manufacturer's quality unit can incorporate into the equipment validation pack supporting the TGA Australian Register of Therapeutic Goods (ARTG) listing, the FDA 510(k) clearance and the CE Marking technical file. This guide is the duct fabricator's perspective on that translation, written for the engineers, project managers, mechanical contractors and quality leads who specify and procure the HVAC duct package on Australian medical device manufacturing projects.

The regulatory stack — ISO 13485, TGO 92, TGA, FDA, CE MDR/IVDR

The regulatory framework for medical device manufacturing in Australia has six interlocking elements that together govern the HVAC duct specification. Understanding the order of precedence is the precondition for issuing a defensible duct package.

ISO 13485:2016 — Medical devices, Quality management systems, Requirements for regulatory purposes is the international consensus standard for the QMS that wraps around the entire manufacturing process. Section 6.3 (Infrastructure) and Section 6.4 (Work environment and contamination control) directly govern the HVAC system — the manufacturer must determine, provide and maintain the infrastructure needed to achieve conformity to product requirements, and must establish documented requirements for environmental conditions including air quality, contamination control and pressure cascade where relevant to the product. ISO 13485 is referenced by TGA, FDA and the EU MDR/IVDR as the underlying QMS standard, and a certified ISO 13485 facility is a near-prerequisite for an ARTG listing of a Class IIa or higher device.

TGO 92 — Therapeutic Goods Order 92, Standard for labelling of medicines is one of the small family of Australian Therapeutic Goods Orders that govern manufacturing standards for therapeutic goods. For medical device manufacturing the dominant orders are TGO 92 (labelling), TGO 91 (medicines labelling, where the device manufacturer also produces accompanying drug product) and the family of Manufacturing Principles documents published by the TGA. TGO 92 sits over the labelling that has to match the manufacturing batch, and the HVAC duct contribution is that the labelling room — typically a dedicated ISO 8 environment — must hold conditions adequate to prevent label misapplication.

TGA Australian Register of Therapeutic Goods (ARTG) is the regulatory listing every device marketed in Australia must hold. The TGA classifies devices into Class I (lowest risk — e.g. tongue depressors), Class IIa (low-medium risk — e.g. surgical mesh, non-invasive imaging), Class IIb (medium-high risk — e.g. CPAP, ventilator, certain orthopaedic), Class III (highest risk — e.g. implantable cardiac stent, cochlear implant, orthopaedic joint replacement) and a separate IVD classification (Class 1 through 4, with Class 4 covering HIV/HCV/blood typing). The HVAC duct specification scales with class — a Class I device manufacturing area may need only basic AS 1668.2 ventilation, whereas a Class III implantable manufacturing area triggers the full ISO 14644 cleanroom stack with 316L stainless welded duct.

FDA 510(k) and PMA apply to any device exported to the US market. The 510(k) clearance route covers devices substantially equivalent to a predicate, and the PMA (Premarket Approval) covers novel Class III devices. FDA inspections of foreign-manufactured product use the same QSIT methodology as domestic inspections, with HVAC scrutinised under 21 CFR 211.46 (Ventilation, air filtration, air heating and cooling) and the broader 21 CFR Part 820 Quality System Regulation. Form 483 observations on the HVAC system can stop an FDA clearance from issuing — a fact that drives the documentation rigour even on the Australian side.

CE Marking — MDR 2017/745 and IVDR 2017/746 are the European medical device regulations that replaced the old MDD/IVDD directives. The MDR covers all medical devices (other than IVDs); the IVDR covers in-vitro diagnostics. Both regulations are substantially stricter than the prior directive regime — they require extensive technical documentation, post-market surveillance, Unique Device Identification (UDI), and Notified Body involvement for most Class IIa and all higher-class devices. The HVAC duct documentation forms part of the technical file submitted to the Notified Body, and a Notified Body assessor (BSI, TÜV SÜD, Dekra, SGS) will request the duct material certs, weld map and leakage test reports during the audit.

The sterilisation standards family — ISO 11135 (EtO), ISO 17665 (moist heat), ISO 11137 (radiation), ISO 14160 (liquid chemical sterilants for single-use medical devices incorporating animal materials), ISO 14937 (general requirements) — governs the cycles by which devices are made sterile, and indirectly governs the HVAC system that supports the sterilisation suite. ISO 11135 in particular drives the EtO exhaust duct specification because the cycle requires controlled aeration and back-vent abatement, and the duct is the safety-critical containment layer.

The order of precedence for a duct specification on an Australian medical device manufacturing facility: (1) any explicit user requirement in the URS issued by the medical device manufacturer's engineering team; (2) the more stringent of TGA, FDA and CE expectations applicable to the product; (3) ISO 13485 infrastructure requirements; (4) the applicable Australian Standards (AS/NZS 4187, AS 1668.2, AS 4254, AS/NZS 60079, AS 1530.4, etc.); (5) the relevant sterilisation cycle standard. A duct package that defaults to AS/NZS 4254 without picking up the cleanroom layer fails inspection. A duct package that picks up the ISO 14644 layer without the Australian Standards has gaps on fire damper integration, smoke management and hazardous area zoning. Both layers are needed.

ISO 14644 cleanroom classification and HVAC duct implications

The cleanroom class is the single most consequential parameter for the medical device duct designer. ISO 14644-1:2015 classifies cleanrooms by maximum airborne particle concentration at the ≥ 0.5 µm size threshold, and gives the duct designer the only quantitative target the system has to meet. The class drives the air change rate, the filter face area, the supply duct cross-section and the kilometres of stainless that have to be welded. Every other decision is downstream.

The classes and their typical medical device application:

• ISO Class 5 / Class 100 / EU Grade A. Maximum 3,520 particles/m³ ≥ 0.5 µm. The aseptic core. Used in medical device manufacturing as the laminar flow workstation over critical operations — cochlear implant electrode array sealing, surgical mesh packaging, cardiac stent crimping, IVD reagent fill. Unidirectional laminar flow at 0.36 to 0.54 m/s face velocity. Equivalent ACH 250 to 600.
• ISO Class 6. Maximum 35,200 particles/m³ ≥ 0.5 µm. Used in some semi-continuous processing zones and in dedicated assembly cells for higher-risk implants. ACH 100 to 180.
• ISO Class 7 / Class 10,000 / EU Grade C. Maximum 352,000 particles/m³ ≥ 0.5 µm in operation. The background environment for ISO 5 critical operations on Class III implantables — cochlear implant assembly background, orthopaedic joint replacement final assembly, surgical mesh inspection. Also used as the primary class for AS/NZS 4187 sterile zone in CSSD-style sub-zones within a manufacturing facility. ACH 30 to 60.
• ISO Class 8 / Class 100,000 / EU Grade D. Maximum 3,520,000 particles/m³ ≥ 0.5 µm in operation. The primary class for non-sterile device assembly — CPAP, ventilator, non-sterile IVD reagent fill, dental implant packaging. Also used for solution preparation and component prep stages of higher-class devices. ACH 5 to 25.
• ISO Class 9. Maximum 35,200,000 particles/m³ ≥ 0.5 µm. Used for cleanroom-adjacent warehousing of components and primary packaging materials. ACH 5 to 20.

For an Australian medical device manufacturing facility the typical class assignment looks like this. A cochlear implant facility (Cochlear Limited at Lane Cove West) will have an ISO 7 background for the assembly cleanroom, ISO 5 laminar flow workstations over the electrode array sealing and final hermetic test, ISO 8 for the receiver-stimulator subassembly cell, ISO 8 for the cleaning and decontamination area, ISO 7 for the AS/NZS 4187 sterile pack sub-zone, ISO 9 for component warehousing. A CPAP and ventilator facility (ResMed at Bella Vista, Mascot or Norwest) will run ISO 8 throughout the assembly, with no ISO 5 critical-operation requirement because the device is not sterile-packed by the manufacturer (the single-use patient-airway tubing is sterilised by a separate contract supplier). An orthopaedic joint replacement facility (Stryker, Zimmer Biomet, J&J DePuy Synthes Australian subsidiary) will have ISO 7 background, ISO 5 laminar flow workstation over the final inspection and pack, ISO 8 for the machining and anodising area. A dental implant facility (Straumann Australia, Megagen Australia, Osstem) will run ISO 7 for the anodising and titanium etch line, ISO 8 for packaging. An IVD reagent fill facility (Abbott Diagnostics, Roche Diagnostics at Dee Why, Beckman Coulter, Sysmex) will have ISO 7 for immunoassay magnetic bead reagent fill, ISO 8 for PCR primer fill, ISO 8 for lateral flow rapid test assembly. A wound dressing facility (Smith+Nephew, ConvaTec) will run ISO 8 throughout. The duct designer's first job on a new project is to map the class assignment to the floor plan and propagate it through the air change rate worksheet.

Cochlear Limited and the bionic hearing supply chain

Cochlear Limited (ASX:COH) is Australia's largest medical device company by market capitalisation and the global market leader in hearing implant technology. The company's headquarters at 1 University Avenue Macquarie Park NSW is co-located with the Macquarie University campus, reflecting the close research partnership with Australian Hearing Hub. Manufacturing concentrates at Lane Cove West NSW where the cochlear implant (CI), Baha (bone-conduction), Osia (active osseointegrated) and Acoustic product families are produced. Cochlear also operates manufacturing footprints internationally but the Australian facility remains the technology and process anchor.

The cochlear implant itself is a Class III implantable medical device. The internal receiver-stimulator is hermetically sealed in a titanium housing approximately 35 mm in diameter and 5 mm thick, with a platinum-iridium electrode array of typically 22 active electrodes extending into the cochlear duct. The hermeticity requirement is severe — the device must remain sealed for 30+ years in the patient body, and any leakage path allows ingress of body fluid that corrodes the internal electronics. Hermeticity is verified by helium mass-spectrometer leak detection at 10⁻⁹ atm·cc/s, an order of magnitude tighter than any non-implantable specification.

The HVAC duct implications for a cochlear implant facility are driven by three process steps. (1) Electrode array sealing — the platinum-iridium electrode array is bonded to the titanium housing using laser welding under inert gas, in an ISO 5 laminar flow workstation. The supply duct to this workstation is 316L fully welded round duct, Ra ≤ 0.5 µm electropolish, leakage class D. (2) Hermetic test — the helium leak test station is supplied by 316L duct with no rectangular section in the cleanroom envelope, because any duct leak in the cleanroom plenum can spoof the helium signal. (3) Sterile pack and AS/NZS 4187 sub-zone — the assembled implant is sterilised by ethylene oxide (EtO) for distribution, and the EtO sterilisation cycle is governed by ISO 11135. The EtO chamber is located in a Zone 1 hazardous area under AS/NZS 60079, the aeration room is Zone 2, and the exhaust duct from chamber and aeration to the abatement scrubber is 316L stainless fully welded, leakage class D, with continuous EtO concentration monitoring alarming to BAS at 0.5 ppm (warning) and 1 ppm (evacuation).

SBKJ engineering supports cochlear implant duct fabrication through the SBTF stainless tubeformer (round duct from 80 mm to 1,500 mm diameter on 316L 0.5 mm to 1.5 mm wall), the SBAL-V auto duct production line re-tooled for stainless rectangular sections where retrofit constraints force them, and the orbital GTAW welding station for transverse joint welding on cleanroom-side supply. The combined fabrication suite delivers the documentation package — 3.1 mill certs per EN 10204, WPS/PQR/WPQ under AWS D18.1, surface finish profilometer logs by spool, pickle and passivate batch records, leakage test reports per EN 1507 — that Cochlear's quality unit appends to the equipment validation pack supporting the TGA ARTG listing, the FDA 510(k) / PMA file and the CE Marking MDR technical documentation.

ResMed and the CPAP / ventilator manufacturing envelope

ResMed (ASX:RMD) is the global market leader in CPAP, ventilator and sleep apnoea therapy by revenue. The company's headquarters at 1 Elizabeth Macarthur Drive Bella Vista NSW anchors a research and manufacturing footprint that extends to Norwest, Mascot and Macquarie Park. ResMed is the largest medical device company in Australia by revenue, dominating the obstructive sleep apnoea (OSA) therapy category through its AirSense, AirCurve, AirMini and AirView product families, and supplying ventilator hardware (Astral, Stellar) into the home, hospital and ambulance markets.

The CPAP and ventilator manufacturing envelope is fundamentally different from the implantable manufacturing envelope. The CPAP device itself is a Class IIb device under TGA — it is not implanted in the patient, it does not contact sterile tissue, and the patient airway interface (mask, tubing, humidifier chamber) is supplied as a separate consumable that is replaced periodically. The device manufacturing area therefore runs to ISO 8 throughout, with no ISO 5 critical operation requirement. The HVAC duct package is physically much larger than a cochlear implant facility — a ResMed-scale manufacturing line produces 1.5 to 3 million CPAP devices per year through 6,000 to 12,000 m² of ISO 8 manufacturing space, compared to perhaps 30,000 to 80,000 cochlear implants per year through 800 m² of ISO 7 envelope — but the per-metre duct specification is lighter.

The duct package for a typical CPAP and ventilator facility comprises: (1) ISO 8 supply duct to the main assembly hall — galvanised steel or 304L stainless lockformed, MERV 13 minimum filtration, H13 HEPA where the URS calls for it (ResMed's internal facility brief sometimes specifies H13 on the final pack zone); (2) general return duct in galvanised or 304L spiral; (3) dedicated exhaust to the moulding shop, where the polymer injection-moulding presses run heat and small amounts of resin off-gas — typically 304L spiral with corrosion-resistant coating; (4) dedicated exhaust to the soldering and electronics assembly cell, with capture velocity at the solder station to comply with SafeWork Australia rosin colophony WES; (5) dedicated exhaust to the testing and burn-in room where motor noise testing and run-in occurs; (6) office and amenity HVAC under the NCC Class 5 envelope. The duct package is high-volume, lower spec — a perfect match for the SBKJ SBAL-V auto duct production line on galvanised, which can produce 1,500 to 2,500 m of duct per shift.

Where the ResMed and CPAP-adjacent manufacturers (Philips Australia, Drager Australia, Vyaire Medical, Air Liquide Healthcare) differ from a generic light-manufacturing facility is in their requirement for product testing under controlled atmosphere. A CPAP device must be performance-tested before pack, which involves running the device against calibrated airflow loads — the test cell is typically conditioned to 23 ± 2 °C and 50 ± 10 % RH to ensure repeatable performance, supplied by a dedicated AHU and stainless duct to keep test condition repeatability tight. Some facilities also have a noise-attenuated chamber for acoustic certification (motor noise to ISO 80601-2-72 ventilator standard), and the supply duct to this chamber requires high attenuation acoustic lining and low face velocity to keep regenerated noise below the chamber's measurement floor.

Surgical and orthopaedic implant manufacturing — the Class III stainless envelope

Surgical and orthopaedic implant manufacturing in Australia is dominated by the local subsidiaries of the global majors — Stryker Australia (Mascot NSW, Bella Vista, Sydney), Zimmer Biomet Australia (Frenchs Forest NSW), Johnson & Johnson DePuy Synthes (Ultimo NSW), Smith+Nephew Australia (Mascot NSW), Medtronic Australia (Macquarie Park NSW), Boston Scientific Australia (Botany NSW), Abbott Australia, Edwards Lifesciences, B. Braun Australia (Bella Vista), DJO Global, Implantcast and Australian Implant Pty Ltd. The product portfolios span hip and knee replacement (Stryker, Zimmer Biomet, J&J DePuy Synthes), trauma fixation (Stryker, Zimmer Biomet, Smith+Nephew), spinal hardware (Medtronic, Stryker, Zimmer Biomet), cardiac stents (Abbott Vascular, Boston Scientific, Medtronic), cardiac rhythm management (Medtronic, Abbott, Biotronik), heart valves (Edwards Lifesciences, Medtronic), surgical mesh (J&J Ethicon, Atrium, Bard), and a long tail of single-procedure implants and instrumentation.

Implantable orthopaedic devices are Class III under TGA. They are sterile-packed, they reside in the patient body for the device's service life (10 to 25 years for a hip or knee, indefinite for a spinal fixation), and any contamination or surface defect introduced during manufacturing can present as infection, debris generation or premature implant failure at any point in the service life. The manufacturing environment is therefore ISO 7 background with ISO 5 laminar flow over final assembly and pack, plus a substantial machining and surface treatment footprint at ISO 8 for the metal forming, anodising, electropolishing, blasting and cleaning steps that precede the cleanroom envelope.

The HVAC duct package for an orthopaedic implant facility has three distinct zones with different specifications. (1) Machining and surface treatment zone — CNC machining of titanium and cobalt-chromium alloy, electropolishing of joint articulating surfaces, anodising of titanium, blasting of porous-coated surfaces. ISO 8 supply, dedicated extract from each surface treatment bath, AS/NZS 60079 hazardous area classification where anodising or electropolish chemistry produces hydrogen evolution (Zone 2 typical), 304L stainless duct for the corrosion environment, galvanised acceptable on supply where the URS allows. (2) Cleanroom assembly zone — ISO 7 background with ISO 5 laminar flow over the final hermetic and visual inspection, the sterile pack stations, and the cycle traceability. 316L stainless supply duct, Ra ≤ 0.8 µm internal, leakage class C/D, EN 1751 class 3 dampers. (3) Sterilisation suite — typically gamma irradiation (contract supplier) or EtO (in-house under ISO 11135). For the EtO sub-zone the duct is 316L fully welded, leakage class D, AS/NZS 60079 Zone 1 inside chamber and Zone 2 in aeration, EtO concentration monitoring with WES alarm at 0.5 ppm warning / 1 ppm STEL evacuation.

The documentation expected by an orthopaedic implant manufacturer's quality unit is essentially identical to the pharma cleanroom documentation set — 3.1 mill certs per EN 10204, WPS/PQR/WPQ records, surface finish profilometer logs, pickle and passivate batch records, leakage test reports, HEPA integrity test reports, weld maps, as-built isometrics, calibration certificates — appended to the equipment validation pack that supports the TGA ARTG listing, FDA 510(k)/PMA and CE Marking MDR technical file. SBKJ delivers this as a controlled-document binder and hyperlinked PDF as standard on cleanroom-grade duct packages.

Dental implant manufacturing — titanium anodising and the surface engineering envelope

Dental implant manufacturing in Australia runs through Straumann Australia, Nobel Biocare Australia, Megagen Australia, Osstem, Anatomic Implants (Australian-owned), AustraDent, Adin Australia, Camlog Australia, Ankylos, Bredent Australia, ICX, Astra Tech (Dentsply-Sirona) Australia, Implant Direct Australia and Australian Implant Pty Ltd. The dental implant itself is typically a commercially pure (CP) grade 4 titanium or Ti-6Al-4V (grade 5) titanium alloy threaded fixture, 8 to 18 mm in length and 3 to 6 mm in diameter, with a surface-engineered roughness profile (SLA, TiUnite, RBM, sandblasted-and-acid-etched) designed to promote osseointegration with the alveolar bone.

The dental implant manufacturing environment differs from the orthopaedic implant in two material respects. First, the volume is higher and the device is smaller — a major dental implant facility produces 500,000 to 1.5 million implants per year through 3,000 to 6,000 m² of manufacturing footprint, compared to perhaps 100,000 to 300,000 hip/knee replacements per year for a major orthopaedic facility through similar footprint. Second, the surface engineering is more chemically aggressive — the SLA (sandblasted, large-grit, acid-etched) surface that Straumann pioneered is produced by hydrofluoric acid etching of the sandblasted surface, generating hydrogen evolution and acid mist that drives strict exhaust capture requirements.

The HVAC duct package for a dental implant facility comprises: (1) ISO 7 supply to the assembly cleanroom — 316L stainless fully welded, Ra ≤ 0.8 µm electropolish, H14 HEPA terminal; (2) ISO 8 supply to the machining and surface treatment area — 304L spiral, MERV 13 supply, H13 HEPA on the surface treatment side; (3) dedicated acid etch exhaust — 316L fully welded with FRP (fibre reinforced plastic) acceptable on the wet portion, AS/NZS 60079 Zone 2 classification where hydrogen evolution occurs in pickling tanks, scrubber abatement before atmospheric discharge; (4) dedicated anodising exhaust — similar to acid etch, with the anodising bath generating chlorine evolution where chloride electrolyte is used; (5) sandblasting cabinet exhaust — 304L spiral with abrasion-resistant lining at elbows, pulse-jet bag filter at termination; (6) sterilisation suite — typically gamma (contract) for high-volume dental implants, with no in-house EtO required for most facilities. Documentation expectations match the orthopaedic case.

IVD in-vitro diagnostic manufacturing — reagent fill and microfluidic assembly

The IVD in-vitro diagnostic manufacturing sector in Australia covers a broad product portfolio from rapid antigen home-test cards (Ellume Medical, Brisbane) through immunoassay magnetic bead reagent fill (Abbott Diagnostics, Roche Diagnostics, Beckman Coulter, Siemens Healthineers, Sysmex) to molecular PCR primer and probe fill (Roche, Hologic, Bio-Rad) and specialist electrophoresis platforms (Sebia). IVD manufacturing is regulated under the TGA IVD Class 1 through 4 framework (with Class 4 covering HIV/HCV/blood typing applications) and under the EU IVDR 2017/746, which is a substantially stricter regulation than the old IVDD that it replaced.

The HVAC duct specification for IVD manufacturing scales with the product. Rapid antigen home test cards (Ellume, Lumos Diagnostics) are typically manufactured in ISO 8 to ISO 9 with no cleanroom critical operation, but with humidity tightly controlled (40 ± 5 % RH) to ensure repeatable lateral flow performance during the membrane lamination step. Immunoassay magnetic bead reagent fill (Abbott Architect platform, Roche Cobas, Beckman Coulter, Sysmex) runs in ISO 7 background with ISO 5 laminar flow over the fill nozzles and capping stations — the reagent product is a sterile-filtered antibody-conjugated bead suspension and microbial ingress would invalidate the calibration curve. Molecular PCR primer fill (Roche, Hologic, Bio-Rad) runs in ISO 7 background with strict separation between pre-PCR (clean) and post-PCR (potentially contaminated) areas to prevent amplicon carry-over contamination — the duct design implements this as separate AHU systems with no shared return, and the pre-PCR area runs at higher pressure than post-PCR. Electrophoresis gel fill (Sebia) and similar specialist products run in ISO 7 to ISO 8 depending on the QMS specification.

An additional factor unique to IVD is the bacterial endotoxin testing requirement under USP <85> — Bacterial Endotoxin Test (LAL — Limulus Amebocyte Lysate test). Reagents that contact patient samples must be endotoxin-free, which means the manufacturing water (Water for Injection grade or equivalent), the reagent fill stations and the primary packaging must all be controlled to a specified endotoxin limit. The HVAC duct contribution is that the LAL test laboratory itself runs as a small ISO 7 sub-zone within the broader manufacturing footprint, supplied by 316L duct with H14 HEPA. Lonza Australia is one of the main LAL reagent suppliers to the Australian IVD industry.

USP <87> (in-vitro biological reactivity) and USP <88> (biological reactivity in-vivo) drive the materials compatibility testing for any plastic component that contacts the patient sample or the reagent stream. The HVAC duct itself does not contact either, but the gasket and sealant bill of materials in any cleanroom serving USP <87> / <88> assembly should reference USP Class VI biocompatibility on the elastomer compounds — SBKJ default cleanroom gasket specification (silicone-free EPDM monolithic, USP Class VI) is built to this expectation.

The EtO sterilisation exhaust — the single most critical duct in the building

Ethylene oxide (EtO) is the dominant industrial sterilant for heat-sensitive and moisture-sensitive medical devices. Devices that cannot tolerate the 121 °C / 134 °C saturated steam temperatures of an autoclave (ISO 17665) — cochlear implant electrode arrays, polymer CPAP componentry, single-use surgical instrumentation, electronic IVD components, latex-free gloves, plastic catheters — are sterilised by EtO cycles under ISO 11135. EtO is also chemically aggressive — it is a Group 1 IARC carcinogen with strong evidence for human leukaemia and breast cancer at occupational exposure, a SafeWork Australia Workplace Exposure Standard (WES) of 1 ppm TWA (time-weighted average) and 1 ppm STEL (short-term exposure limit), and a flammable explosion hazard at concentrations above 3 % in air.

The EtO duct system is therefore the safety-critical containment element of the building. Catastrophic failure of an EtO exhaust duct has been the single largest cause of medical device manufacturing facility shutdowns in the last decade — both in Australia and globally — and EtO emission has been the cause of major facility closures in the US (notably the Sterigenics Willowbrook closure in 2019 that affected the supply chain for many global medical device OEMs). The Australian regulator (SafeWork Australia, EPA in each state) takes EtO emissions extremely seriously, and any duct system serving an EtO sterilisation suite must be designed, fabricated, validated and operated to a containment standard that prevents any pathway by which EtO can migrate from the sterilisation suite into a normally occupied space or to atmosphere above the EPA discharge limit.

The full EtO duct system has six elements. (1) Chamber back-vent. At the end of the EtO injection and dwell phase the chamber is vented back to atmosphere via the abatement scrubber. The back-vent duct is 316L stainless fully welded, sized for the peak transient flow (typically 50 to 150 m³/min for a 10 to 30 m³ chamber), AS/NZS 60079 Zone 1 classification within the duct envelope. (2) Aeration room exhaust. After back-vent the products are transferred to the aeration room where residual EtO outgasses from the polymer matrix over 8 to 48 hours. The aeration room exhaust runs continuously at typically 6 to 12 air changes per hour, on 316L stainless fully welded duct, AS/NZS 60079 Zone 2 classification, with a dedicated fan and abatement train. (3) Abatement scrubber duct. Both chamber back-vent and aeration exhaust route through a catalytic or wet-scrubber abatement train that destroys EtO before atmospheric discharge — typical destruction efficiency 99.5 to 99.9 %. The duct connecting the scrubber stages is 316L fully welded with FRP acceptable on the wet scrubber wet section. (4) Pre-conditioning room exhaust. Before sterilisation the load is pre-conditioned at temperature and humidity in a separate room — the exhaust on this room is light-duty 304L spiral, low EtO risk because product has not yet been sterilised. (5) Operator emergency exhaust. A separate emergency extract fan activates on EtO concentration alarm to draw any leaked EtO out of the operator space — 316L stainless, high capacity (typically 30 to 60 ACH on demand), interlocked to the EtO monitor at 1 ppm STEL setpoint. (6) BAS monitoring. Continuous EtO concentration monitoring at multiple points in the suite, with alarm setpoints at 0.5 ppm (warning, increased ventilation) and 1 ppm (STEL, evacuation), tied to the building automation system with audit trail.

Failure modes that SBKJ engineering has seen on EtO duct systems in the medical device industry include: corrosion-induced perforation of carbon-steel duct that was substituted for stainless during value engineering; leakage at slip joints that were specified instead of welded joints; flange-gasket failure where the gasket material was not chemically compatible with EtO at concentration; fan shaft seal leakage where the fan was not specified for AS/NZS 60079 hazardous area service; and abatement scrubber bypass where an isolation damper failed open under transient pressure. Each of these is a controllable failure mode that disappears with a properly specified, properly fabricated and properly documented duct package. SBKJ delivers EtO duct as 316L fully welded, EN 1751 class 4 isolation dampers, AS/NZS 60079 zoned and certified fans, continuous EtO monitoring tied to BAS, and a full ISO 11135-aligned documentation pack ready for TGA, FDA and CE inspection.

Steam autoclave, hydrogen peroxide plasma, gamma, E-beam — the broader sterilisation duct framework

EtO is one of five major sterilisation modalities used in the medical device industry, and each has its own duct implications. The full sterilisation duct framework that SBKJ engineers cover on Australian medical device manufacturing projects:

• Steam autoclave — ISO 17665 / AS/NZS 4187 cycles. Saturated steam at 121 °C (for 15-minute cycles) or 134 °C (for 3.5-minute cycles), the workhorse sterilisation for heat-stable surgical instruments, reusable trays, and selected metal implants. The duct interface is a vent line that handles the chamber discharge and condensate. 316L stainless duct sized for the vent flow rate, externally insulated to AS/NZS 4859.1 to prevent surface scalding hazard, with atmospheric break and condensate trap to prevent backflow.
• Hydrogen peroxide H₂O₂ plasma — STERRAD platform. Low-temperature (typically 45 °C) sterilisation suitable for heat-sensitive devices including endoscopes, cameras and electronic components. H₂O₂ is a strong oxidiser with SafeWork Australia WES of 1 ppm TWA and 2 ppm STEL. The duct system is 316L stainless fully welded with FRP acceptable on the wet scrubber section, leakage class C/D, continuous H₂O₂ monitoring with WES alarm. Sterrad-equivalent platforms from Belimed and Getinge sit in this category.
• Gamma irradiation — ISO 11137, ARPANSA-licensed. Cobalt-60 source delivering 25 kGy nominal dose to penetrate polymer and metal packaging. Used by the major Australian contract sterilisation suppliers (Steris Australia, Steriflow, Sterigenics-equivalent suppliers) for high-volume single-use device packaging. The on-site duct interface is the ventilation of the irradiator cell, maintained under negative pressure relative to the operator corridor, with isolation dampers interlocked to source position, ARPANSA radiation safety officer sign-off on the duct route, and continuous monitoring of ozone evolved by ionising radiation (ozone WES 0.1 ppm TWA / 0.3 ppm STEL).
• E-beam irradiation — ISO 11137. Electron-beam accelerator delivering similar dose to gamma but with shallower penetration. Used in smaller-scale and integrated medical device manufacturing lines. Duct framework similar to gamma but with the source effectively cold when off (no continuous source like Co-60), so the isolation requirements are less stringent.
• Liquid chemical sterilisation — ISO 14160. Peracetic acid, glutaraldehyde, or other liquid chemical sterilants used for single-use devices incorporating animal tissue (collagen wound dressing, porcine heart valve). The duct framework is a process exhaust over the open tank, 316L stainless fully welded with FRP acceptable on the wet section, scrubber abatement before atmospheric discharge, AS/NZS 60079 Zone 2 classification where flammable solvent vapour is present.
• Ozone sterilisation. Niche modality for heat-sensitive devices, ozone generated on-demand from oxygen. Ozone WES 0.1 ppm TWA / 0.3 ppm STEL, duct 316L stainless fully welded with continuous ozone monitoring.

The duct designer's job on a multi-modality sterilisation suite is to keep each modality's exhaust separated — there is no benefit and substantial risk to combining EtO exhaust with H₂O₂ exhaust on a shared duct, even if the abatement train at termination is identical. SBKJ engineering delivers separate dedicated exhaust on each sterilisation modality with separated abatement, joining only at atmospheric discharge through a common stack with separated discharge points.

AS/NZS 4187 sterile reprocessing — the CSSD-style sub-zone

AS/NZS 4187 — Reprocessing of reusable medical devices in health service organisations — is most often associated with hospital Central Sterile Services Departments (CSSD). It is, however, also the governing standard for any portion of a medical device manufacturer's facility where reusable items are decontaminated and re-sterilised between batches, or where reusable items are returned from the field for refurbishment. SBKJ engineering routinely sees AS/NZS 4187 sub-zones inside larger medical device manufacturing facilities — typical examples:

• Cochlear implant returned-device refurbishment. Cochlear Limited operates a returned-device programme for clinician evaluation of explanted implants — these arrive contaminated with patient tissue and require AS/NZS 4187-compliant decontamination before they can enter the analytical laboratory.
• Surgical instrument tray refurbishment. Stryker, Zimmer Biomet, J&J DePuy Synthes operate reusable instrument tray programmes — clinician-returned trays are decontaminated, inspected, repaired and re-sterilised inside an AS/NZS 4187-compliant sub-zone.
• CPAP humidifier chamber refurbishment. ResMed and Philips operate take-back programmes for reusable humidifier chambers — incoming chambers are AS/NZS 4187-decontaminated before warehousing.
• IVD analyser sample loading rack reprocessing. Abbott, Roche, Beckman Coulter operate reusable sample loading racks on their analytical platforms — the rack reprocessing on the manufacturer's side is AS/NZS 4187.
• Returned dental implant evaluation. Straumann, Nobel Biocare, Megagen operate explanted-implant evaluation programmes — incoming explants are decontaminated under AS/NZS 4187 before analysis.

The HVAC duct framework for an AS/NZS 4187-compliant sub-zone within a medical device facility:

• Physical separation between dirty (decontamination), clean (inspection, packing) and sterile (post-autoclave storage) areas, with airlocks at every interface.
• Pressure cascade dirty < clean < sterile, typically 15 Pa step between zones.
• Air change rate 10 ACH minimum in clean and sterile zones, 15 ACH in decontamination, supplied from a dedicated AHU not shared with general manufacturing.
• Filtration H13 HEPA minimum on supply to clean and sterile zones, MERV 13 acceptable on decontamination supply.
• Exhaust direct to outside from decontamination, no recirculation, sized at the room exhaust plus 25 % over-pressurisation allowance.
• Material 316L stainless on supply to clean and sterile zones, 304L stainless or galvanised acceptable on supply to decontamination, 316L stainless on exhaust from decontamination.
• Temperature and humidity 18 to 22 °C, 35 to 60 % RH in clean and sterile zones, 18 to 25 °C in decontamination.

SBKJ duct packages for medical device manufacturers routinely include an AS/NZS 4187-compliant sub-zone as a sub-set of the broader cleanroom envelope, with the boundary defined by the airlocks and the dedicated AHU. The documentation expectations are identical to the cleanroom case — 3.1 mill certs, WPS/PQR/WPQ, surface finish logs, pickle and passivate batch records, leakage test reports, HEPA integrity reports, weld maps, as-built isometrics, calibration certificates.

AS/NZS 60079 hazardous area — EtO, anaesthetic gas, solvent, Li-ion battery R&D

AS/NZS 60079.10.1 (gases and vapours) and AS/NZS 60079.10.2 (combustible dusts) are the Australian standards for hazardous area classification — the framework that determines where ignition sources must be controlled to prevent fire or explosion. On a medical device manufacturing facility AS/NZS 60079 zones typically apply in four locations:

• EtO sterilisation suite. Zone 1 inside the EtO chamber and within 3 m of the abatement vent, Zone 2 in the aeration room and within the EtO suite envelope. EtO flammable concentration is above 3 % in air, well above the typical operating concentration but the hazardous classification accounts for credible leak scenarios.
• Anaesthetic gas and medical gas storage. Where the facility holds anaesthetic gas (sevoflurane, desflurane, isoflurane) or nitrous oxide N₂O for product development testing — Zone 1 inside the cylinder store, Zone 2 in the surrounding space. Oxygen at high partial pressure is not flammable but accelerates combustion — separate classification.
• Spray finish and solvent-based adhesive cells. Where the product manufacturing involves spray coating (some orthopaedic implants receive a porous-coating that is spray applied), solvent-based adhesive cure (some IVD assembly), or other VOC-emitting process — Zone 1 inside the spray booth, Zone 2 in the surrounding cell.
• Li-ion battery R&D. Where the facility includes a lithium-ion battery development cell (rare on medical device sites but present at companies with implantable electronic devices that include rechargeable batteries — Cochlear, Medtronic, ResMed) — Zone 2 classification with explosion-resistant ventilation and battery-fire suppression.

The HVAC duct implications for any Zone 1 or Zone 2 hazardous area:

• Antistatic continuity. The duct must maintain electrical continuity from end to end, with bonding straps across flange joints, earth bonding to the building earth at a frequency of every 6 m or at every fan, and resistance to earth tested at commissioning.
• Explosion-resistant fan construction. Fans serving Zone 1 must be Ex e or Ex d certified, with shaft seals rated for the flammable atmosphere, motors mounted outside the airstream where possible, and spark-resistant impeller materials.
• Isolation dampers at every cross-zone tie-in, EN 1751 class 4, with positive position feedback to the BAS.
• Explosion-relief panels on the duct where the credible explosion overpressure exceeds the duct hoop strength — sized per AS/NZS 60079.10 and the duct supplier's rating.
• Continuous gas monitoring at multiple points in the suite, with alarm setpoints below the relevant WES and below the lower explosive limit.

SBKJ duct fabrication for AS/NZS 60079 hazardous area service follows the same machinery line-up as cleanroom duct — SBTF stainless tubeformer for spiral 316L, SBAL-V auto duct line for rectangular sections, orbital GTAW for welded joints — with the additional requirement that every spool carries a continuity test record and the welded joints are leak-tested to EN 1507 class D regardless of the cleanroom requirement on the same run.

Pressure cascade design — the cleanroom's defence in depth

ISO 14644 classification tells you what is allowed inside a room at steady state. The pressure cascade is what keeps the dirtier air outside. On a medical device manufacturing facility the cascade also keeps the EtO inside the sterilisation suite and outside the cleanroom, keeps the cytotoxic exhaust on the contained side and away from the operator, and keeps the AS/NZS 4187 sterile zone protected from the decontamination zone.

The cascade has to deliver this on every operating scenario — including door-open transients, single HEPA failure, single fan failure, and emergency power switchover. Industry practice in medical device manufacturing is a 15 Pa step gradient between adjacent zones, with the cleanest zone at the highest pressure (in cleanroom logic) and the most contaminated zone at the lowest pressure (in sterilisation and CSSD logic). A typical cochlear implant facility cascade:

• External corridor: 0 Pa reference.
• Component warehouse (ISO 9 / unclassified): +5 Pa.
• Gowning room 1 (ISO 8): +15 Pa.
• Gowning room 2 (ISO 8): +30 Pa.
• ISO 7 background corridor: +45 Pa.
• ISO 7 assembly cleanroom: +60 Pa.
• ISO 5 laminar flow workstation: +60 Pa background with localised unidirectional flow.

Parallel to this, the EtO suite cascade runs in the opposite direction (negative pressure):

• External corridor: 0 Pa reference.
• EtO pre-conditioning room: -15 Pa.
• EtO chamber room: -30 Pa.
• EtO aeration room: -45 Pa.
• EtO chamber interior (during cycle): -60 Pa or as specified by the OEM.

And the AS/NZS 4187 sub-zone cascade:

• External corridor: 0 Pa reference.
• Soiled drop-off airlock: -10 Pa.
• Decontamination zone: -15 Pa (or +5 Pa if the dirty side has dedicated exhaust direct to outside).
• Clean prep and inspection zone: +20 Pa.
• Sterile pack and storage zone: +30 Pa.

The duct designer's three knobs to make the cascade stable are: supply fan modulation through VFD, room exhaust modulation through stainless control dampers, and the leakage class of the duct itself. A leaking duct upstream of a HEPA terminal can pressurise the ceiling plenum and undermine the cascade. A leaking duct downstream of the EtO chamber back-vent can release EtO into a normally occupied space. The leakage class is a non-negotiable structural element of the cascade, not a downstream tolerance — which is why class D leakage performance is the default on cleanroom supply, contained exhaust and EtO duct in the SBKJ specification.

HEPA / ULPA terminal filter integration

The HEPA filter is what actually delivers the cleanroom class. The duct system's job is to deliver the right air volume at the right velocity to the upstream face of the filter, with enough filter face area, enough seal pressure and enough physical access for in-place leak testing. The terminal classification chain on a medical device facility:

• H13. ≥ 99.95 % MPPS retention. Typical for ISO 7 / ISO 8 supply terminals where the filter is the primary contamination-control element. Used on most CPAP and ventilator assembly supply.
• H14. ≥ 99.995 % MPPS retention. The default for ISO 7 background on implantable Class III manufacturing and for ISO 5 laminar flow ceilings over critical operations.
• U15. ≥ 99.9995 % MPPS retention. Used in restricted access barrier systems (RABS) and isolators on the very highest-risk operations — selected cochlear implant electrode array sealing, high-potency drug-device combination products.
• U16. ≥ 99.99995 % MPPS retention. Specialist applications including some cell-therapy and gene-therapy manufacturing isolators.

The duct connection to the terminal housing is one of the highest-risk integration points. Three rules apply on every Grade A / B equivalent terminal that SBKJ fabricates: the duct must enter the housing through a fully welded, leak-tested transition; the upstream sample / injection port for in-place DOP / PAO challenge testing must be accessible without breaking the cleanroom envelope; and the downstream side of the filter must allow scan testing per ISO 14644-3 or IEST-RP-CC034.

Material selection — 316L vs 304L vs galvanised on a medical device site

The material selection decision on a medical device site has three layers — cleanroom layer, sterilisation layer, and general manufacturing layer.

Cleanroom layer. Supply to ISO 5/6/7 implantable Class III cleanroom is 316L stainless. Supply to ISO 7/8 Class IIa/IIb assembly is 304L stainless or galvanised with epoxy coating where the URS allows. Supply to ISO 8 non-sterile device assembly (CPAP, ventilator) is 304L stainless or galvanised. Return duct (any class) is 304L stainless or galvanised in most projects.

Sterilisation layer. EtO chamber back-vent and aeration exhaust is 316L stainless fully welded. Steam autoclave vent is 316L stainless. H₂O₂ plasma exhaust is 316L stainless. Gamma irradiator cell ventilation is 304L acceptable except where chloride exposure (cleaning chemistry) drives 316L. Liquid chemical sterilant exhaust is 316L stainless with FRP on the wet scrubber section.

General manufacturing layer. Office, amenity and warehouse HVAC is galvanised steel under AS/NZS 4254. Production floor HVAC outside the cleanroom envelope is galvanised. CNC machining shop exhaust is galvanised with abrasion-resistant lining at elbows. Soldering cell exhaust is galvanised. Polymer moulding shop exhaust is galvanised with corrosion-resistant coating where the URS calls for it.

The L designation on stainless (low carbon, ≤ 0.03 %) matters because medical device cleanroom duct is welded, and welding higher-carbon grades risks chromium carbide precipitation at the heat-affected zone (sensitisation). Always specify 316L and 304L on welded duct. Material certification is by 3.1 mill test certificate per EN 10204 on every heat, Positive Material Identification by handheld XRF at goods-in and on selected finished spools, and traceability of heat number through fabrication to as-built weld map.

For deeper background on stainless versus galvanised material selection see SBKJ's separate guide on galvanised versus stainless steel duct.

Surface finish — Ra 0.5 µm electropolish, 2B mill, mechanical polish

Surface finish on medical device cleanroom duct is specified, measured and certified. The four finishes encountered, ranked from least to most stringent:

• 2B mill finish. The default cold-rolled, annealed, lightly skin-passed finish on stainless coil. Internal surface roughness Ra typically 0.3 to 1.0 µm. Acceptable for ISO 7/8 cleanroom and most return / exhaust duct.
• 2D mill finish. Cold rolled, annealed, no skin pass — slightly rougher than 2B. Less common in medical device cleanroom duct.
• #4 brushed finish. Mechanical polish with abrasive belt, Ra 0.4 to 0.8 µm depending on grit. Used on duct exteriors in visible cleanroom locations and on some ISO 7 supply duty.
• Electropolish. Electrochemical removal of surface micro-asperities, leaves a passive chromium-rich oxide layer. Achievable Ra ≤ 0.5 µm routinely, ≤ 0.25 µm on best practice. Default for ISO 5 supply, for high-purity gas distribution, and for any duct that has to be cleanable in place.

Finish is measured by contact profilometer per ISO 4287 or ASME B46.1, on a sample frequency of one read per spool minimum, three reads per spool on ISO 5 supply duct. SBKJ uses Mitutoyo SJ-410 profilometers and issues finish certificates by spool with a calibration trace.

The relationship between Ra and microbiological cleanability is well established. Below Ra ≈ 0.8 µm, biofilm formation rate falls steeply. Below Ra ≈ 0.4 µm the rate is essentially zero on a routine cleaning cycle. This is the engineering basis for the Ra ≤ 0.5 µm specification on ISO 5 supply duct — it is not arbitrary, it tracks the size of the contamination problem.

Pickle and passivate — restoring stainless after welding

Welding 316L creates heat tint (rainbow oxide layer at the heat-affected zone), weld scale (dark slag on the bead) and an invisible disruption of the chromium oxide passive layer. Pickle and passivate is the chemical process that fixes all three, and it is required on every welded stainless duct fabrication.

The governing standards: ASTM A380 (standard practice for cleaning, descaling and passivation of stainless steel parts), ASTM A967 (standard specification for chemical passivation treatments), ISO 16048 (passivation of corrosion-resistant stainless-steel parts).

The two-stage process: pickle with a nitric-hydrofluoric acid blend (typical 10–15 % HNO₃ + 1–3 % HF) at 20–40 °C for 15–60 minutes to remove heat tint and weld scale; then passivate with nitric acid (typical 20 % HNO₃) at 20–50 °C for 20–30 minutes to restore the chromium oxide layer. Triple rinse with deionised water between stages and after the passivate step. Drain and dry under filtered air.

Verification by FerroxylTM test or copper sulphate test on a witness coupon per batch. A passivated surface shows no blue stain in FerroxylTM and no copper deposition in copper sulphate. Pass / fail is recorded against the batch.

SBKJ's stainless duct shop has a dedicated pickle-and-passivate line with closed-loop chemistry, automated rinse, neutralised effluent treatment and certified batch records on every duct package.

Welding — orbital GTAW, qualification, weld maps

Stainless welding for medical device cleanroom duct is dominated by orbital GTAW (TIG with argon back purge), with manual GTAW used for fittings and tie-ins by a qualified welder. The orbital process gives consistent, low-distortion, low-heat-input welds with minimal sugaring (chromium-depleted oxide on the back side) when the back purge is correctly maintained.

The qualification framework is AWS D18.1 (Specification for welding of austenitic stainless steel tube and pipe systems in sanitary applications) or ASME Section IX (Welding and Brazing Qualifications). For each base material, thickness, joint design and process the fabricator must issue a Weld Procedure Specification (WPS) backed by a Procedure Qualification Record (PQR) with mechanical and macro test results. Each individual welder must hold a current Welder Performance Qualification (WPQ) for the specific procedure they will run.

The weld map is the controlled-document record of every weld in the project — weld number, weld type (longitudinal seam or transverse joint), welder ID, WPS reference, date, inspection status, repair history if any. The weld map is the document an FDA, EMA, MHRA or TGA inspector will request first on an Aseptic Processing Inspection (API) or Pre-Approval Inspection (PAI). SBKJ delivers the weld map as a controlled-document register tied to the as-built isometric set.

For deeper background on welding process selection see SBKJ's welding methods for HVAC duct fabrication guide.

Damper specification — cleanroom and contained exhaust

Dampers are the moving parts of the cleanroom duct system. On a medical device facility three damper categories appear:

• Volume control dampers (VCDs). Modulating dampers that trim air flow per branch under building automation system (BAS) control. On ISO 5/6/7 branches SBKJ specifies stainless damper blades and shafts, low-leakage shaft seals (PTFE or graphite-impregnated), pneumatic actuator with positive position feedback (4–20 mA loop), and EN 1751 leakage class 3 minimum.
• Pressure-relief dampers. Single-direction barometric dampers protecting against over-pressurisation under transient events. Spring-loaded or counterweighted. Stainless for cleanroom, galvanised acceptable for general manufacturing.
• Isolation dampers. Bubble-tight (zero leakage) dampers for EtO contained exhaust, for cytotoxic compounding contained exhaust on radiopharmaceutical sites, and for cross-suite isolation during decontamination cycles. EN 1751 class 4 with positive-pressure shaft seal. Pneumatic actuator with limit switches confirming open and closed positions.

Leakage class governed by EN 1751:2014:

• Class 1: ≤ 175 mL/(s·m²) at 1,000 Pa. Commercial only.
• Class 2: ≤ 56 mL/(s·m²) at 1,000 Pa. Commercial.
• Class 3: ≤ 18 mL/(s·m²) at 1,000 Pa. Medical device cleanroom standard for ISO 5/6/7 supply.
• Class 4: ≤ 5 mL/(s·m²) at 1,000 Pa. EtO exhaust, cytotoxic exhaust, isolation dampers.

Validation — leakage testing per IEST-RP-CC006 and EN 1507

Once the duct is fabricated, installed and pickled-and-passivated, it has to be tested. Leakage testing is mandatory on every medical device cleanroom duct system. The two governing standards: IEST-RP-CC006 (Institute of Environmental Sciences and Technology) and EN 12237 / EN 1507 (European Standards for ductwork strength and leakage).

Test method: the duct section is sealed at both ends, pressurised by a calibrated fan to the test pressure (typically 1,000 Pa for supply, 1,500 Pa for contained exhaust including EtO, 500 Pa for general extract), and leakage flow measured by an orifice plate or calibrated rotameter on the inlet line. Leakage is reported in L/s/m² of duct surface area. Pass/fail against the applicable class.

Class D under EN 1507, the default for medical device cleanroom and EtO exhaust, allows ≤ 0.009 L/s/m² at 1,000 Pa. On a 100 m² duct surface area at 1,000 Pa the maximum allowable leakage is 0.9 L/s — slightly less than one litre per second over an area the size of a small tennis court. Achieving class D requires welded seams, gasket-and-sealant flanged joints correctly applied, and damper-and-filter housing leak tightness designed in from the start.

Test instrumentation must be calibrated with NIST-traceable certificates. SBKJ uses Setra and Dwyer calibrated manometers. The test report includes duct identification, surface area, test pressure, measured leakage, calculated L/s/m², leakage class, ambient conditions, instrument calibration reference, witness signatures and date. Every report goes into the IQ documentation.

HEPA terminal integrity testing is a separate process under ISO 14644-3 and IEST-RP-CC034. The terminal is challenged upstream with DOP (di-octyl phthalate, increasingly replaced by PAO due to phthalate concerns) at a defined upstream concentration, the downstream side is scanned with a photometer. Penetration must be ≤ 0.01 % at any point on the filter face. Terminals failing the scan are repaired (gel-seal injection on the gasket interface) or replaced. Annual re-test on most medical device facilities.

Documentation — material certs, WPS, WPQ, PMI, weld maps

A medical device cleanroom duct turnover package SBKJ delivers contains, at minimum:

• 3.1 Mill Test Certificates per EN 10204. One per heat of stainless used. Chemical composition, mechanical properties, heat number, steelmaker stamp.
• Positive Material Identification (PMI) Reports. XRF spectroscopy per heat number, performed at goods-in and on representative finished spools.
• Weld Procedure Specifications (WPS). One per joint configuration / process / base material / thickness combination. Qualified per AWS D18.1 or ASME Section IX.
• Procedure Qualification Records (PQR). The supporting test record for each WPS, with mechanical and macro test results.
• Welder Performance Qualifications (WPQ). One per welder per process per position, current to project execution date (typically 6 months validity).
• Surface finish profilometer logs. One reading per spool minimum, three per spool on ISO 5. Ra values, calibration trace, instrument serial number.
• Pickle and passivate batch records. Solution chemistry analysis, contact time, rinse confirmation, FerroxylTM or copper sulphate test results per batch.
• Leakage test reports. Per duct section, per IEST-RP-CC006 or EN 1507, with calibration trace.
• HEPA integrity test reports. Per terminal, per ISO 14644-3.
• Weld maps. Drawings showing every weld with weld number, welder ID, WPS reference, date.
• As-built isometric drawings. Updated through commissioning.
• Calibration certificates. For every test instrument — manometers, rotameters, profilometers, photometers, XRF analysers, EtO monitors.
• Declaration of Conformity. Referencing AS/NZS 4254, AS 1668.2, AS/NZS 60079, AS/NZS 4187, ISO 14644, ISO 13485 as applicable.

The documentation pack typically runs 300 to 800 A4-equivalent pages for a 1,500 to 3,000 m duct package, delivered as a controlled binder and as hyperlinked PDF. It is the deliverable the TGA, FDA or CE Marking Notified Body assessor will review first.

Case study — cochlear implant facility, 2,800 m of welded 316L duct

A representative cleanroom duct package SBKJ engineering supports — anonymised but technically representative of multiple recent projects in the Australian medical device sector:

• Facility. Greenfield cochlear implant manufacturing line on the NSW eastern seaboard, single ISO 7 assembly cleanroom plus dedicated electrode array sealing cell (ISO 5 LF), helium leak test cell (ISO 5 LF), EtO sterilisation suite (Zone 1/2), AS/NZS 4187 sterile pack sub-zone, component warehouse.
• Cleanroom inventory. 1 × ISO 7 assembly background (480 m²), 2 × ISO 5 laminar flow workstations (each 6 m² ceiling area), 1 × ISO 7 sterile pack zone (180 m²), 1 × ISO 8 component prep (220 m²), 1 × ISO 9 / unclassified warehouse (380 m²).
• Air volume. 124,000 m³/h total supply, of which 38,000 m³/h to ISO 7 assembly, 16,000 m³/h to ISO 5 laminar flow ceilings, 22,000 m³/h to ISO 7 sterile pack, 18,000 m³/h to ISO 8 component prep, 12,000 m³/h to ISO 9 warehouse, 18,000 m³/h to corridors and gowning. Recirculation 75 % overall.
• Duct package. 2,800 m total. 1,950 m fully welded 316L round duct (orbital GTAW, electropolish Ra ≤ 0.5 µm internal). 600 m sealed rectangular 304L on ISO 8 supply and return. 250 m spiral lockformed 304L on building exhaust and warehouse return.
• EtO suite. 1 × 12 m³ EtO chamber, 1 × 250 m² aeration room, 1 × abatement scrubber train. 180 m of dedicated 316L stainless fully welded duct, EN 1507 class D, AS/NZS 60079 Zone 1/2 classified, continuous EtO monitoring 4 points alarming to BAS at 0.5/1 ppm.
• Filters. 18 × H14 terminal HEPA on ISO 7 assembly, 12 × H14 on ISO 5 laminar flow ceilings, 14 × H14 on ISO 7 sterile pack, 22 × H13 on ISO 8 component prep, 8 × H13 on ISO 9 warehouse.
• Welding scope. 1,420 transverse welds plus 1,950 m of longitudinal seam. 5 qualified orbital GTAW welders. 100 % visual inspection, 12 % radiographic on ISO 5 supply, 8 % radiographic on ISO 7, 6 % radiographic on EtO.
• Pressure cascade. ISO 7 assembly +60 Pa, ISO 5 LF +60 Pa background with localised unidirectional flow, ISO 7 sterile pack +75 Pa, ISO 8 component prep +30 Pa, ISO 9 warehouse +5 Pa, corridor 0 Pa reference. EtO suite -30 Pa (room) / -45 Pa (aeration) / -60 Pa (chamber cycle). AS/NZS 4187 sub-zone: dirty -15 Pa, clean +20 Pa, sterile +30 Pa.
• Documentation. 562-page turnover binder including 28 mill certificates, 12 WPS, 18 PQR, 5 WPQ, 2,800 line items in the surface finish log, 22 pickle/passivate batch records, 36 leakage test reports (class D pass on every section), 124 HEPA integrity test reports, EtO containment certification per ISO 11135, AS/NZS 60079 hazardous area dossier.
• Schedule. 22 weeks from approved isometrics to ex-works. 8 weeks installation on site under SBKJ engineering supervision. 6 weeks IQ/OQ/PQ.
• Regulatory outcome. TGA conformity assessment passed first attempt. FDA Pre-Approval Inspection (PAI) passed on first attempt with zero Form 483 observations on the HVAC system. CE Marking MDR Notified Body audit (BSI) passed with one minor observation on documentation indexing, closed within 14 days.

SBKJ machinery line-up for medical device duct fabrication

For Australian medical device manufacturers and their mechanical contractors building cleanroom-grade duct, SBKJ supplies the full machinery stack. The headline machines:

• SBAL-V Auto Duct Production Line. Full-spec rectangular duct line, galvanised or stainless coil 0.6 to 1.5 mm wall, integrated Pittsburgh or seam-weld option, TDF flange integrated, length tolerance ± 1 mm. The default machine for the ISO 8 supply on CPAP / ventilator manufacturing and for the ISO 7/8 supply on dental implant and IVD manufacturing where rectangular sections fit the architecture. See the auto duct line catalogue.
• SBAL-III Auto Duct Production Line. Mid-spec rectangular duct line for general manufacturing supply, return and exhaust outside the cleanroom envelope. The default machine for office, amenity and warehouse HVAC on medical device sites.
• SBTF Stainless Spiral Tubeformer (SBTF-1500 / SBTF-1602 / SBTF-2020). 304/304L/316/316L coil to 1,500 mm / 1,600 mm / 2,000 mm diameter, mandrel-formed flush internal seam, AC servo drive, Siemens or Mitsubishi PLC, length tolerance ± 1 mm/m. The default machine for spiral lockformed cleanroom return, exhaust and ISO 7/8 supply duct on medical device sites. See the spiral tubeformer catalogue.
• SBSF-1525 Shrinking and Flaring Machine. Precision end-treatment for spiral and round duct — shrinks one end and flares the other for slip-fit transitions, taper-fit fittings and reducer integration. Used downstream of the SBTF tubeformer on every spool that needs a non-flanged transition.
• SB-ZF1500 Angle Iron Auto Line. Roll-formed angle iron for TDF-style flange fabrication and structural duct framing. Used to produce the flange profiles on rectangular duct lines.
• SBFB-1500 Flange Punch. Automated bolt-hole punching on flange profiles to integrate with TDF flange and bolt-up flange architectures.
• SBPC1500 Plasma Cutter. CNC plasma cutting on stainless and galvanised coil — used to produce duct end-caps, custom fittings, access doors, register frames and BIM-driven duct development.
• SBLR-600 Leveller. Coil levelling pre-form to ensure flat, consistent feed into the tubeformer and auto duct line — critical for the dimensional repeatability required on cleanroom-grade duct.

For medical device cleanroom duct production lines SBKJ pairs the SBTF tubeformer with a stainless-grade automated welding station for transverse joint welding (orbital GTAW), a pickle-and-passivate station with closed-loop chemistry, and a profilometer-equipped surface inspection cell. The combined line produces 316L cleanroom-grade duct end-to-end from coil to certified spool.

Commercial model — machinery turnkey or finished duct supply

SBKJ supports two commercial routes for the Australian medical device manufacturing customer.

Route A: machinery turnkey. SBKJ supplies the complete cleanroom duct fabrication line — SBTF tubeformer, SBAL-V or SBAL-III auto duct line, orbital welding stations, pickle-and-passivate, inspection — and the customer fabricates in-house or through a partner fabricator. SBKJ provides operator training in Box Hill North or on-site, welder qualification support to AWS D18.1, a process flow for the documentation regime aligned with ISO 13485 expectations, and 12 months of remote engineering support. This route suits OEMs and large medical device manufacturers with in-house fabrication capability or established mechanical contractors with stainless welding experience.

Route B: finished duct supply. SBKJ supplies the finished welded 316L duct package ex-works the SBKJ stainless duct shop, including all documentation, leakage testing and HEPA integrity testing. This route suits one-off projects, small-batch programmes and customers without in-house pharma-grade fabrication. The duct ships flat-pack in serialised crates with a controlled-document binder per project. Installation is by the customer's mechanical contractor under SBKJ engineering supervision (remote or on-site).

Both routes are supported from SBKJ's Australian office at Box Hill North VIC for English-speaking technical handover. Initial engineering reply within 12 hours of enquiry. SBKJ engineers attend ARBS 2026 at Sydney ICC under stand 236 alongside Australia Ducting Pty Ltd — visit the stand for a face-to-face technical discussion with our cleanroom duct engineering team.

Fire, smoke and life-safety duct integration

Beyond the cleanroom and sterilisation envelope, every medical device manufacturing facility carries the standard suite of fire, smoke and life-safety duct integration requirements under the Australian Standards stack:

• AS 1530.4 — Methods for fire tests on building materials, components and structures. The test method for fire resistance level (FRL) on duct penetrations of fire-rated boundaries. Every penetration of a fire-rated wall, floor or ceiling must be sleeved and dampered to maintain the FRL of the construction.
• AS 1668.1 — The use of mechanical ventilation and air-conditioning in buildings, Part 1: Fire and smoke control. Mandates smoke spill ducts on larger facilities, dedicated smoke exhaust on certain occupancies, and the requirements for smoke dampers at smoke compartment boundaries.
• AS 1668.3 — Smoke control. Detailed smoke management framework for larger and higher-risk facilities including Class 9a (healthcare) and Class 9b (assembly) — note that a medical device manufacturing facility is typically NCC Class 8 (industrial) plus Class 5 (office) plus, where adjacent to CSSD-style operations, Class 9a-adjacent.
• AS 4214 — Gaseous fire-extinguishing systems. Where the facility uses gaseous suppression (FM-200, Novec 1230, inert gas) in dedicated risk areas (server rooms, electronics cabinets, robot cells), the gaseous suppression duct interface is governed here.
• AS 2118 — Automatic fire sprinkler systems. Pre-action sprinkler is common in cleanroom and high-value manufacturing areas where accidental wet sprinkler discharge would cause unacceptable product loss — the pre-action system has air-pressurised piping that is monitored continuously.
• AS 1670 — Fire detection, warning, control and intercom systems. Detection in supply, return and exhaust duct is standard on cleanroom AHUs and on EtO exhaust.

The NCC classification on a typical medical device manufacturing facility is a mix: Class 8 (industrial — production floor), Class 5 (office — administration), Class 7b (storage — warehouse), and Class 9a-adjacent (where there is a CSSD-style sub-zone). For an integrated medical device manufacturing campus the building classifier produces a mixed-class building, and the HVAC duct designer has to satisfy each class's requirements within its envelope. Fire dampers are scheduled at every penetration of a fire-rated boundary; smoke dampers at smoke compartment boundaries; smoke detection in supply and return duct on cleanroom AHUs; gaseous suppression interfaces on high-value equipment cabinets. SBKJ duct packages on medical device facilities include the fire and smoke damper schedule as a sub-set of the broader duct schedule, with FRL-tested damper assemblies (typically Halton, Trox, Belimo, Greenheck) specified to match the wall, floor or ceiling construction.

Other Australian Standards and industry frameworks worth knowing

Beyond AS/NZS 4254 (the duct construction standard), AS 1668.2 (ventilation), AS/NZS 4187 (reprocessing), AS/NZS 60079 (hazardous area) and AS 1530.4 (fire), the medical device manufacturing duct designer encounters a long tail of supporting Australian Standards and industry frameworks:

• AS 1428.1 — Design for access and mobility, the Disability Discrimination Act (DDA) standard applied to building access. Affects the location of mechanical access doors, plant room entries and emergency exits.
• AS/NZS 2982 — Laboratory fume cupboards. Where the medical device manufacturing facility includes a quality control laboratory (and they all do), fume cupboard exhaust is governed here.
• AS/NZS 2243.3 — Safety in laboratories, Part 3: Microbiological safety and containment. Where the facility includes a PC2 biocontainment laboratory (cell culture using HEK293, HEK293T, Vero, SF9, or E. coli K12 BSL-1 cleanroom expression systems) the PC2 ventilation framework applies — class II biosafety cabinet with HEPA exhaust to the duct or to atmosphere, BMBL-equivalent practices, no recirculation from PC2 to non-PC2 space.
• ISO 14971 — Application of risk management to medical devices. The cross-cutting risk management standard referenced by ISO 13485 and the TGA, FDA and CE regulatory pathways. The HVAC duct contribution is that the risk assessment must include credible failure modes of the duct system (loss of cascade, EtO leakage, HEPA failure, fire damper failure to close) and the mitigation strategy must be documented.
• ISO 9001, ISO 14001, ISO 45001 — Quality management, environmental management, occupational health and safety management. The supporting management system standards that wrap around ISO 13485 on most manufacturers.
• USP <797> — Pharmaceutical compounding, sterile preparations. Applies to any radiopharmaceutical compounding (Telix Illuccix Ga-68 PSMA-11 PET fill) and to drug-device combination products. ISO 5 critical site, ISO 7 buffer area.
• USP <800> — Hazardous drugs handling. Applies to cytotoxic and other hazardous drug compounding. Drives containment exhaust and negative-pressure cascade.
• ARPANSA — Australian Radiation Protection and Nuclear Safety Agency. Licenses ionising radiation including gamma sterilisation, X-ray inspection (used on cardiovascular catheter and stent quality control), and on-site E-beam where applicable.
• RANZCR, RACS, ANZCA — Royal Australian and New Zealand College of Radiologists, Royal Australasian College of Surgeons, Australian and New Zealand College of Anaesthetists. The clinical colleges that issue guidance on medical device interface with clinical practice, sometimes referenced in the manufacturer's URS for surgical or anaesthetic interface devices.
• Medical Technology Association Australia (MTAA) — the peak body for medical device manufacturers in Australia. Issues sector guidance and represents members at the TGA.
• ANDHealth — Australian National Digital Health peak body. Where the device is a digital health product or connected medical device, ANDHealth guidance applies.

SafeWork Australia Workplace Exposure Standards (WES) — the operator-side ceiling

SafeWork Australia publishes the Workplace Exposure Standards (WES) that set the legal ceiling for operator exposure to airborne hazards. On a medical device manufacturing facility the WES values that drive HVAC duct design:

• Ethylene oxide (EtO): 1 ppm TWA, 1 ppm STEL. Group 1 IARC carcinogen. The killer for EtO sterilisation suite design.
• Hydrogen peroxide H₂O₂: 1 ppm TWA, 2 ppm STEL. Strong oxidiser. Drives the H₂O₂ plasma sterilisation duct spec.
• Ozone O₃: 0.1 ppm TWA, 0.3 ppm STEL. Generated by ionising radiation, UV-C sterilisation, gamma irradiation. Drives the gamma suite exhaust spec.
• Chlorine Cl₂: 1 ppm STEL. Generated in anodising baths with chloride electrolyte. Drives the dental implant and orthopaedic anodising exhaust spec.
• Hydrogen fluoride HF: 3 ppm TWA, 5 ppm STEL. Used in acid-etch baths for dental implant SLA surface preparation. Drives the etch-bath exhaust spec.
• Nitrous oxide N₂O: 25 ppm TWA. Used in anaesthetic interface device testing. Drives the medical-gas store and test area exhaust.
• Sevoflurane, desflurane, isoflurane: No specific WES, but recommended scavenging to keep operator exposure below 2 ppm. Drives the anaesthetic interface device test area exhaust.
• Glutaraldehyde: 0.05 ppm STEL. Used in liquid chemical sterilant cycles. Drives the ISO 14160 process exhaust.
• Rosin colophony (soldering flux): 0.05 mg/m³ TWA. Drives the soldering cell exhaust on CPAP, ventilator and electronic IVD manufacturing.

The duct designer's job is to size the ventilation rate to keep operator exposure below the WES with a credible margin — typical engineering practice is to design to 25 % of the WES as the steady-state operating concentration, leaving margin for transient excursions and instrument drift. The duct material, leakage class, isolation damper rating and continuous monitoring strategy follow from the WES.

Energy efficiency and NABERS — the cleanroom HVAC operating cost reality

Cleanroom HVAC is the largest single energy load on a medical device manufacturing facility — typically 40 to 65 % of total site electricity consumption. The high air change rates (250 to 600 ACH on ISO 5, 30 to 60 ACH on ISO 7) drive substantial fan kW, the HEPA filter pressure drops drive additional fan kW, the cooling load on the conditioned makeup air drives chiller kW, and the heating load in winter (Melbourne, Sydney) or shoulder seasons (Perth, Brisbane) drives boiler or heat-pump kW.

Energy efficiency on medical device cleanroom HVAC is delivered through six levers: (1) recirculation rate — typically 70 to 85 % of cleanroom air is recirculated through the HEPA terminal rather than once-through, dramatically reducing the outdoor-air conditioning load; (2) variable frequency drive (VFD) on supply and return fans with closed-loop pressure cascade control, allowing the system to modulate to actual demand rather than running at design point continuously; (3) heat recovery on the exhaust — typically a run-around coil between exhaust and supply, sometimes a plate heat exchanger where the building geometry allows; (4) demand-controlled ventilation where the cleanroom is unoccupied — many facilities run a setback mode overnight that drops to 25 % of design ACH while maintaining cascade; (5) low-pressure-drop duct sizing — keeping the velocity below 8 m/s on main supply trunks reduces fan kW by 30 to 50 % compared to the SMACNA upper-band velocities; (6) low-pressure-drop HEPA filter selection — modern minipleat HEPA filters at 50 to 80 Pa pressure drop replace older deep-pleat HEPA at 150 to 250 Pa.

NABERS (National Australian Built Environment Rating System) is the Australian energy and water benchmarking framework. NABERS Energy and NABERS Water are increasingly required by lease tenants and by progressive medical device manufacturers in their facility brief. NABERS for Offices is well-established, NABERS for Healthcare is growing, and NABERS for Manufacturing is emerging — Cochlear, ResMed and Nanosonics are among the larger Australian medical device manufacturers publishing NABERS-aligned environmental reporting. The HVAC duct designer's contribution to NABERS rating is delivered through the six levers above — and SBKJ engineering routinely supports NABERS-rated duct design through low-pressure-drop sizing, recirculation optimisation and heat recovery integration.

BIM, digital twin and the modern medical device duct project

Large medical device manufacturing projects in Australia have adopted Building Information Modelling (BIM) as the default project delivery method, with the major engineering consultants (Aurecon, Arup, GHD, Lendlease, Hassell, JHA) issuing the duct design as a Revit MEP model rather than as 2D drawings. SBKJ engineering supports BIM-driven duct fabrication through three integration points:

• Native Revit family library — SBKJ-published Revit families for SBAL-V duct sections, SBTF spiral duct, common fittings (elbows, tees, reducers, end caps, access doors) loaded with manufacturer-specific dimensional and material parameters that propagate into the model's bill of materials.
• BIM-to-CNC handoff — direct export from Revit fabrication data to the SBPC1500 plasma cutter and the SBAL-V auto duct line via standard interchange formats (DXF for plasma cutting, native PLC recipe for the duct line), eliminating the manual re-drawing step that introduces error on complex projects.
• As-built model update — the duct package on a medical device project must be tracked through installation and commissioning, and the final as-built Revit model carries the spool serial numbers, weld map references, leakage test results and HEPA integrity test results as model parameters — the duct turnover package becomes a navigable digital twin rather than a static binder.

For deeper coverage of BIM-integrated duct fabrication see SBKJ's separate guide on BIM integration for HVAC duct fabrication.

Common pitfalls — value engineering, schedule pressure, scope ambiguity

Three failure modes recur on Australian medical device cleanroom duct projects, and they are worth flagging explicitly because SBKJ engineering sees them on a recurring basis when called in to remediate an underperforming installation.

Value engineering on duct material. The single most common pitfall is substituting galvanised steel for stainless on cleanroom supply duct during the value engineering phase of a project. The proposal usually comes from a mechanical contractor who is bidding the work and is looking to reduce the duct cost line by 30 to 45 %. The defence is the URS: if the URS specifies 316L stainless on supply to ISO 5/6/7, the substitution is non-compliant and the project quality lead should reject it. SBKJ's role on value engineering is to point at the URS, document the rejection, and offer alternative cost reductions on the schedule, the lead time or the fabrication route (such as spiral 304L instead of welded 316L on cleanroom return) that do not compromise the regulatory compliance.

Schedule pressure on documentation. The second pitfall is treating the documentation as a downstream deliverable that can be assembled at the end of the project. This is wrong. The documentation has to be generated synchronously with the fabrication — every spool is profilometer-tested before it leaves the bath, every weld is welder-stamped and weld-mapped as it is run, every batch of pickle-and-passivate produces a witness coupon test result that goes in the batch record. Trying to assemble this retrospectively at handover always reveals gaps that require expensive rework. SBKJ delivers the documentation as the fabrication progresses, with the controlled-document binder index built up week-by-week and shared with the customer's quality unit in real time.

Scope ambiguity at the cleanroom interface. The third pitfall is uncertainty at the interface between the cleanroom shell contractor (typically a specialist cleanroom contractor such as Plenary Cleanrooms, Pharmout, Connell Industries) and the mechanical duct contractor. The cleanroom shell typically includes the ceiling plenum and the HEPA terminal housings; the mechanical duct package typically stops at the upstream face of the terminal. If this boundary is not crisply defined in the scope of work, the duct contractor and the cleanroom contractor will both assume the other has scope of the transition spool — and the project will discover the gap at commissioning. SBKJ engineering recommends a written interface matrix issued at project kick-off that defines who supplies, installs and tests every component within 1 m of the terminal — typically the SBKJ duct contractor supplies and installs the transition spool, the cleanroom contractor supplies and installs the terminal housing, and the leakage test on the spool-to-housing interface is a joint sign-off.

Looking ahead — connected devices, mRNA, gene therapy, AI-enabled diagnostics

The Australian medical device manufacturing landscape is evolving. Cochlear's product roadmap is integrating wireless connectivity and on-implant signal processing — the manufacturing process is becoming more electronics-intensive and is starting to look more like a high-reliability semiconductor packaging operation than a traditional implant operation. ResMed's product roadmap is integrating connected-care platforms (AirView), turning the CPAP into the patient-touching node of a connected respiratory-care ecosystem with the data layer manufactured by a separate software organisation. Nanosonics is expanding the trophon platform into new probe categories. Compumedics is integrating AI-enabled signal interpretation. Polynovo is scaling NovoSorb production. Telix is scaling Illuccix and the related radiopharmaceutical pipeline. The broader Australian medical device manufacturing sector is also seeing investment in mRNA vaccine manufacturing (the federal mRNA Pilot Manufacturing Centre and the state-level mRNA Victoria initiative), in gene therapy and cell therapy CDMO capacity (Cell Therapies Pty Ltd, Cellevolve), in AI-enabled IVD diagnostic platforms (Sienna Diagnostics, Lumos Diagnostics), and in domestic surgical robot manufacturing.

Each of these emerging segments brings new HVAC duct requirements. mRNA vaccine fill-finish requires the full pharma cleanroom stack at ISO 5/7 (covered in SBKJ's pharma biotech cleanroom guide). Gene and cell therapy manufacturing brings PC2 biocontainment requirements under AS/NZS 2243.3 with single-pass air on the GMP-equivalent suite. AI-enabled IVD manufacturing brings the same ISO 7/8 cleanroom envelope as conventional IVD but with denser electronic assembly. Surgical robot manufacturing brings semiconductor-equivalent precision in the camera, sensor and end-effector cells. The HVAC duct designer's response is the same toolkit — ISO 14644 cleanroom classification, AS/NZS 4187 sub-zone where reprocessing applies, AS/NZS 60079 hazardous area where solvent or flammable gas applies, 316L stainless fully welded supply on the cleanroom envelope, leakage class C/D, EN 1751 class 3/4 dampers, HEPA H13/H14 terminal, documentation aligned with ISO 13485 expectations.

SBKJ engineering watches the Australian medical device manufacturing landscape continuously through participation in ARBS (the Australian Refrigeration, Building Services and Sustainability exhibition — SBKJ at stand 236 at Sydney ICC for ARBS 2026), through engagement with MTAA (Medical Technology Association Australia) and through direct support to mechanical contractors working with Cochlear, ResMed, Nanosonics, Stryker, Zimmer Biomet, J&J DePuy Synthes, Smith+Nephew, Medtronic, Boston Scientific, Abbott, Edwards Lifesciences, Straumann, Nobel Biocare, Megagen, Osstem, Roche Diagnostics, Abbott Diagnostics, Beckman Coulter, Siemens Healthineers, BD Becton Dickinson, Bio-Rad, Sysmex, Hologic, Sebia, Lonza, Planet Innovation, Mac Medical, Adept, Compumedics, Polynovo, Telix Pharmaceuticals, Ellume Medical, Sienna Diagnostics, Lumos Diagnostics, Smith Therapeutics, ConvaTec, Coloplast, Hartmann, Molnlycke Health Care, Ansell, Air Liquide Healthcare, Philips Australia, Drager Australia, Vyaire Medical, 3M Australia, STERIS, Belimed, Getinge and Sterling Sterilisation.

Request a medical device duct package quotation →

FAQ

Which Australian medical device manufacturers drive the duct spec on a cleanroom fit-out?

The ASX-listed primes are Cochlear (cochlear implant — Macquarie Park HQ, Lane Cove West manufacturing), ResMed (CPAP/ventilator — Bella Vista, Norwest, Mascot), Nanosonics (trophon ultrasound probe disinfection — Macquarie Park HQ, Lane Cove West), Compumedics (neurodiagnostic — Abbotsford VIC), Polynovo (NovoSorb scaffold — Port Melbourne) and Telix Pharmaceuticals (radiopharmaceutical). Surgical and orthopaedic implant manufacturing runs through the Australian subsidiaries of Stryker, Zimmer Biomet, J&J DePuy Synthes, Smith+Nephew, Medtronic, Boston Scientific, Abbott and Edwards Lifesciences. Dental implant through Straumann, Nobel Biocare, Megagen, Osstem and Anatomic Implants. IVD through Abbott Diagnostics, Roche Diagnostics, Beckman Coulter, Siemens Healthineers, BD, Bio-Rad, Sysmex, Hologic, Sebia and Lonza. Specialist contract manufacturers include Planet Innovation, Mac Medical and Adept.

What cleanroom class does a typical medical device line require?

Product-driven. Implantable Class III (cochlear, orthopaedic, cardiac, surgical mesh, dental) typically targets ISO 7 background with ISO 5 laminar flow workstations over critical operations. CPAP and ventilator (non-sterile devices) typically runs ISO 8 throughout. Dental implant machining and anodising runs ISO 7 downgrading to ISO 8 in packaging. IVD reagent fill runs ISO 7 or ISO 8 depending on product (immunoassay magnetic bead fill ISO 7, lateral flow rapid test ISO 8). The duct designer translates the class into ACH, filter face area and pressure cascade.

Why is the EtO exhaust the most critical duct on a medical device site?

Because ethylene oxide is a Group 1 IARC carcinogen with a SafeWork Australia WES of 1 ppm STEL, and the duct is the safety-critical containment layer. Catastrophic failure of an EtO exhaust duct has been the single largest cause of medical device manufacturing facility shutdowns in the last decade. SBKJ delivers EtO duct as 316L stainless fully welded, EN 1507 class D leakage, AS/NZS 60079 Zone 1/2 classified, with continuous EtO monitoring alarming to BAS at 0.5 ppm warning and 1 ppm STEL evacuation, full ISO 11135-aligned documentation.

How does AS/NZS 4187 apply to a medical device manufacturer rather than a hospital CSSD?

AS/NZS 4187 applies to any manufacturer that reprocesses reusable items between batches — surgical instrument trays, CPAP humidifier chambers, IVD analyser sample loading racks, returned implants for evaluation. The HVAC implication is that the sub-zone where these items are decontaminated, dried, inspected, packed and re-sterilised must meet AS/NZS 4187 environmental requirements: physical separation between dirty, clean and sterile; pressure cascade; 10 ACH minimum in clean and sterile, 15 ACH in decontamination; HEPA H13 supply; direct-to-outside exhaust from decontamination.

What stainless grade and surface finish does ISO 13485 expect?

ISO 13485 does not prescribe directly — the grade and finish come from the ISO 14644 classification and the URS. Industry consensus adopted by Cochlear, ResMed, Stryker, Zimmer Biomet, Straumann, Roche Diagnostics: 316L on supply to ISO 5/6/7 implantable Class III; 304L acceptable on ISO 7/8 Class IIa/IIb assembly; galvanised acceptable on Grade D-equivalent. Surface finish Ra ≤ 0.5 µm electropolish on ISO 5 supply, Ra ≤ 0.8 µm electropolish or 2B mill ≤ 1.0 µm on ISO 7 supply, 2B mill on ISO 8 supply and on return / exhaust.

How does cochlear and surgical implant manufacturing differ from CPAP and ventilator from a duct perspective?

Implantable Class III devices are sterile-packed and reside in the patient body — manufacturing at ISO 7 / Grade C background with ISO 5 / Grade A laminar flow over critical operations, 316L stainless supply, leakage class C/D, Ra ≤ 0.8 µm. CPAP and ventilator are non-sterile devices — manufacturing at ISO 8 / Grade D-equivalent, galvanised or 304L stainless acceptable, 2B mill finish. The trade-off is volume: cochlear at 30,000–80,000 devices/year through 800 m² of ISO 7; CPAP at 1.5–3 million devices/year through 6,000–12,000 m² of ISO 8. Both fit the SBKJ machinery portfolio — SBAL-V on high-volume CPAP, SBTF stainless plus orbital GTAW on cochlear and implant.

What documentation does an Australian medical device manufacturer expect in the turnover package?

3.1 mill certs per EN 10204, PMI XRF reports, WPS/PQR/WPQ under AWS D18.1 or ASME Section IX, surface finish Ra logs by spool, pickle and passivate batch records with FerroxylTM test results, leakage test reports per IEST-RP-CC006 or EN 1507, HEPA integrity test reports per ISO 14644-3, weld maps, as-built isometrics, calibration certificates, Declaration of Conformity referencing applicable Australian Standards. Typically 300–800 pages for a 1,500–3,000 m duct package. Delivered as controlled-document binder and hyperlinked PDF.

How does SBKJ support Australian medical device manufacturers from Box Hill North VIC?

Two commercial routes. Route A: machinery turnkey — SBKJ supplies the complete duct fabrication line (SBAL-V, SBAL-III, SBSF-1525, SB-ZF1500, SBFB-1500, SBPC1500, SBLR-600, SBTF-1500/1602/2020) and the customer fabricates in-house or through a partner. Route B: finished duct supply — SBKJ supplies welded 316L cleanroom duct ex-works the SBKJ stainless duct shop with full ISO 13485-aligned documentation. Both routes supported from Box Hill North VIC for English-speaking technical handover. SBKJ at ARBS 2026 stand 236 at Sydney ICC. Initial engineering reply within 12 hours.